RPTX - Repare Therapeutics Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
159,521
334,427
326,184
94,797
Other short-term investments
184,420
7,439
7,526
-
Total cash
343,941
341,866
333,710
94,797
Other current assets
5,715
6,314
6,678
719
Total current assets
353,979
351,414
346,552
98,572
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
9,599
13,095
8,622
4,520
Accumulated depreciation
-5,353
-3,375
-1,993
-1,096
Net property, plant and equipment
9,599
13,095
8,622
3,424
Other long-term assets
497
586
500
567
Total non-current assets
10,096
17,301
10,534
4,123
Total assets
364,075
368,715
357,086
102,695
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
461
2,302
2,251
2,127
Taxes payable
1,240
523
18
218
Accrued liabilities
21,645
18,622
5,975
229
Deferred revenues
53,102
11,921
2,073
-
Other current liabilities
271
377
184
4
Total current liabilities
78,619
35,089
11,014
4,246
Non-current liabilities
Deferred revenues
2,682
39,613
55,934
8,142
Total non-current liabilities
5,939
45,205
59,242
144,578
Total liabilities
84,558
80,294
70,256
148,824
Stockholders' equity
Common stock
482,032
480,699
384,313
1
Retained earnings
-239,313
-210,266
-103,358
-49,941
Accumulated other comprehensive income
-428
-
-
-
Total stockholders' equity
279,517
288,421
286,830
-46,129
Total liabilities and stockholders' equity
364,075
368,715
357,086
102,695